Literature DB >> 25467043

Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.

Priya Bhide1, Merve Dilgil2, Anil Gudi2, Amit Shah2, Charity Akwaa2, Roy Homburg2.   

Abstract

OBJECTIVE: To ascertain if subfertile women with polycystic ovary syndrome (PCOS) secrete more antimüllerian hormone (AMH) per antral follicle than control women.
DESIGN: Observational cross-sectional study.
SETTING: Fertility clinic. PATIENT(S): A total of 438 women attending the fertility clinic over a period of 13 months from September 2012 to September 2013. INTERVENTION(S): Serum concentrations of AMH and the total antral follicle count (AFC) were obtained from women attending the fertility clinic. The ratio of AMH/AFC for each subject was calculated. Women were categorized into three groups: PCOS, polycystic ovarian morphology (PCOM), and control. PCOS and PCOM were defined based on the European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine Rotterdam consensus criteria. MAIN OUTCOME MEASURE(S): The ratio of AMH/AFC for each subject in the three groups: PCOS, PCOM, and control. RESULT(S): The median AMH/AFC ratios in the PCOS, PCOM, and control groups were 1.92, 1.13, and 1.00, respectively. The AMH/AFC ratio was significantly higher in the PCOS group compared with the PCOM and control groups (F[2,152] = 21.82). Women in the three groups were not statistically different regarding age, body mass index, earlier ovarian surgery, and smoking status. CONCLUSION(S): Subfertile women with PCOS secrete significantly more AMH per antral follicle than women with PCOM only and control women.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimüllerian hormone (AMH); antral follicle count (AFC); polycystic ovarian morphology (PCOM); polycystic ovarian syndrome (PCOS)

Mesh:

Substances:

Year:  2014        PMID: 25467043     DOI: 10.1016/j.fertnstert.2014.10.033

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Antimüllerian hormone in relation to tobacco and marijuana use and sources of indoor heating/cooking.

Authors:  Alexandra J White; Dale P Sandler; Aimee A D'Aloisio; Frank Stanczyk; Kristina W Whitworth; Donna D Baird; Hazel B Nichols
Journal:  Fertil Steril       Date:  2016-05-27       Impact factor: 7.329

2.  Differential response of AMH to GnRH agonist among individuals: the effect on ovarian stimulation outcomes.

Authors:  Jiali Cai; Lanlan Liu; Juan Zheng; Ling Zhang; Xiaoming Jiang; Ping Li; Aiguo Sha; Jianzhi Ren
Journal:  J Assist Reprod Genet       Date:  2017-12-21       Impact factor: 3.412

3.  Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients.

Authors:  Loes M E Moolhuijsen; Yvonne V Louwers; Anke McLuskey; Linda Broer; Andre G Uitterlinden; Renée M G Verdiesen; Ryan K Sisk; Andrea Dunaif; Joop S E Laven; Jenny A Visser
Journal:  Hum Reprod       Date:  2022-06-30       Impact factor: 6.353

Review 4.  Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review.

Authors:  Agathe Dumont; Geoffroy Robin; Sophie Catteau-Jonard; Didier Dewailly
Journal:  Reprod Biol Endocrinol       Date:  2015-12-21       Impact factor: 5.211

5.  Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome.

Authors:  Thozhukat Sathyapalan; Ahmed Al-Qaissi; Eric S Kilpatrick; Soha R Dargham; Brian Keevil; Stephen L Atkin
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

6.  Gene Expression in Granulosa Cells From Small Antral Follicles From Women With or Without Polycystic Ovaries.

Authors:  Lisa Ann Owens; Stine Gry Kristensen; Avi Lerner; Georgios Christopoulos; Stuart Lavery; Aylin C Hanyaloglu; Kate Hardy; Claus Yding Andersen; Stephen Franks
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

Review 7.  Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.

Authors:  Ewa Rudnicka; Michał Kunicki; Anna Calik-Ksepka; Katarzyna Suchta; Anna Duszewska; Katarzyna Smolarczyk; Roman Smolarczyk
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

8.  Decrease in serum anti-Müllerian hormone level per puncture with laparoscopic ovarian drilling using ultrasonically activated device.

Authors:  Shuichi Ogawa; Yusuke Atsuki; Kazuhiko Shimada; Mitsuhiro Motoyama; Tatsuya Suzuki; Hiroyuki Fujiwara
Journal:  Reprod Med Biol       Date:  2021-07-31

9.  Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?

Authors:  Sverre C Christiansen; Tina B Eilertsen; Eszter Vanky; Sven M Carlsen
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

Review 10.  Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.

Authors:  Didier Dewailly; Anne-Laure Barbotin; Agathe Dumont; Sophie Catteau-Jonard; Geoffroy Robin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.